Accuracy of Lactate Meter in GSDIa
ConditionGlycogen Storage Disease Type Ia
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age0-60
SponsorConnecticut Children's Medical Center
About this trial
The goal of this observational study is to determine if home lactate meters (both capillary and serum sample) are accurate, compared to lab serum lactate in a population of patients with glycogen storage disease type 1a and to determine if the Accu Chek Guide glucometer (capillary sample) is accurate, in a population of patients with glycogen storage disease type 1a.
Eligibility criteria
Qualifiers
Patients with diagnosed/confirmed (by liver biopsy or genetic testing) Glycogen Storage Disease Type Ia (ICD 10 code: E74.01).
Connecticut Children's Emergency Department visit and/or admission to Connecticut Children's during time study is active
For pediatric participants: Ability of child's parent/legal guardian to understand and the willingness to sign a written informed consent document
For adults: Ability to understand and the willingness to sign a written informed consent
Disqualifiers
Patients with Glycogen storage disease unspecified 74.00, or Ib
Patients not meeting inclusion criteria
Trial design
Treatments tested in this trial
- blood glucose meter; blood lactate meter
Treatment groups
No treatment groups listed
Sponsors and collaborators
Connecticut Children's Medical Center
Lead sponsor
Global Center for Glycogen Storage Disease held at the Jewish Community Foundation
Collaborator
Source ClinicalTrials.gov